quinuclidines has been researched along with Brain Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shu, Y; Yang, Y; Zhang, P | 1 |
| Altay, O; Duris, K; Krafft, PR; Lekic, T; Rolland, WB; Tang, J; Zhang, JH | 1 |
2 other study(ies) available for quinuclidines and Brain Edema
| Article | Year |
|---|---|
Neuroprotective effects of penehyclidine hydrochloride against cerebral ischemia/reperfusion injury in mice.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Infarction; Capillary Permeability; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione Peroxidase; In Situ Nick-End Labeling; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neurologic Examination; Neuroprotective Agents; Quinuclidines; Reperfusion Injury; Superoxide Dismutase; Time Factors | 2016 |
α7 nicotinic acetylcholine receptor agonism confers neuroprotection through GSK-3β inhibition in a mouse model of intracerebral hemorrhage.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Apoptosis; Behavior, Animal; Benzamides; Blotting, Western; Body Water; Brain Chemistry; Brain Edema; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Caspase 3; Caspase Inhibitors; Fluorescent Antibody Technique; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Intracranial Hemorrhages; Male; Mice; Neurons; Neuroprotective Agents; Nicotinic Agonists; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinuclidines; Receptors, Nicotinic; Signal Transduction; Stroke; Treatment Outcome | 2012 |